| scholarly article | Q13442814 |
| P2093 | author name string | Li Ma | |
| Ilyas Washington | |||
| Yardana Kaufman | |||
| P2860 | cites work | Enhanced accumulation of A2E in individuals homozygous or heterozygous for mutations in BEST1 (VMD2) | Q57784622 |
| Ocular Age Pigment “A2-E”: An Unprecedented Pyridinium Bisretinoid | Q57903209 | ||
| Retinal age pigments generated by self-assembling lysosomotropic detergents | Q59071585 | ||
| Vitamin A in human eyes: amount, distribution, and composition | Q70339094 | ||
| Liver stores of vitamin A in a normal population dying suddenly or rapidly from unnatural causes in New York City | Q71658320 | ||
| Age-related increase in liver retinyl palmitate. Relationship to lipofuscin | Q72303032 | ||
| Formation of lipofuscin-like fluorophores by reaction of retinal with photoreceptor outer segments and liposomes | Q73175950 | ||
| Clinical development plan: vitamin A | Q73344836 | ||
| Ab initio studies of | Q73733300 | ||
| Inhibition of lysosomal degradative functions in RPE cells by a retinoid component of lipofuscin | Q74586647 | ||
| Study of the Electrocyclization of (Z)-Hexa-1,3,5-triene and Its Heterosubstituted Analogues Based on Ab Initio and DFT Calculations | Q77052040 | ||
| Proline promoted synthesis of ring-fused homodimers: self-condensation of alpha,beta-unsaturated aldehydes | Q79395811 | ||
| Superoxidation of bisretinoids | Q81346679 | ||
| Journal of cellular biochemistry. Supplement | Q96319501 | ||
| Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapy | Q24621941 | ||
| Metabolic basis of visual cycle inhibition by retinoid and nonretinoid compounds in the vertebrate retina | Q28587431 | ||
| Isolation and one-step preparation of A2E and iso-A2E, fluorophores from human retinal pigment epithelium | Q28610021 | ||
| Reductions in Serum Vitamin A Arrest Accumulation of Toxic Retinal Fluorophores: A Potential Therapy for Treatment of Lipofuscin-Based Retinal Diseases | Q29012269 | ||
| Prevalence of age-related macular degeneration in the United States | Q29614964 | ||
| Superoxidation of retinoic acid | Q33435091 | ||
| Accelerated accumulation of lipofuscin pigments in the RPE of a mouse model for ABCA4-mediated retinal dystrophies following Vitamin A supplementation | Q33777110 | ||
| Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR-mediated retinal and macular degeneration | Q33905581 | ||
| Effects of potent inhibitors of the retinoid cycle on visual function and photoreceptor protection from light damage in mice | Q33931582 | ||
| Lipofuscin accumulation, abnormal electrophysiology, and photoreceptor degeneration in mutant ELOVL4 transgenic mice: a model for macular degeneration | Q33932466 | ||
| The lipofuscin component A2E selectively inhibits phagolysosomal degradation of photoreceptor phospholipid by the retinal pigment epithelium | Q34020740 | ||
| Fluorescent pigments of the retinal pigment epithelium and age-related macular degeneration | Q34286193 | ||
| Molecular mechanisms of retinoid action. | Q34361053 | ||
| Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration | Q34960196 | ||
| The lipofuscin fluorophore A2E perturbs cholesterol metabolism in retinal pigment epithelial cells | Q35865044 | ||
| High-performance liquid chromatography and laser desorption/ionization mass spectrometry of retinyl esters | Q36885128 | ||
| Rpe65 Leu450Met variant is associated with reduced levels of the retinal pigment epithelium lipofuscin fluorophores A2E and iso-A2E. | Q37415751 | ||
| Safety of vitamin A. | Q38220061 | ||
| A2E, a lipofuscin fluorophore, in human retinal pigmented epithelial cells in culture. | Q40919605 | ||
| Small molecule RPE65 antagonists limit the visual cycle and prevent lipofuscin formation | Q42164095 | ||
| Inhibition of RPE lysosomal and antioxidant activity by the age pigment lipofuscin. | Q42512253 | ||
| The stability of rhodopsin and opsin; effects of pH and aging | Q42853978 | ||
| Mechanism of the inhibition of lysosomal functions in the retinal pigment epithelium by lipofuscin retinoid component A2-E | Q43734234 | ||
| Vitamins and trace elements in age-related macular degeneration. Current recommendations, based on the results of the AREDS study | Q44023449 | ||
| Detergent-like effects of the lipofuscin retinoid component A2-E in retinal pigment epithelial cells | Q44215219 | ||
| Formation of a nonaoxirane from A2E, a lipofuscin fluorophore related to macular degeneration, and evidence of singlet oxygen involvement | Q44255419 | ||
| The retinoid cycle and retina disease | Q44651677 | ||
| Inhibition of the ATP-driven proton pump in RPE lysosomes by the major lipofuscin fluorophore A2-E may contribute to the pathogenesis of age-related macular degeneration | Q44722952 | ||
| Observation of A2E oxidation products in human retinal lipofuscin | Q44809785 | ||
| Dietary intake of selected vitamins for the United States population: 1999-2000. | Q44815433 | ||
| Synthesis and biological activity of novel retinamide and retinoate derivatives | Q44888253 | ||
| Racial variations in causes of vision loss in nursing homes: The Salisbury Eye Evaluation in Nursing Home Groups (SEEING) Study | Q46811103 | ||
| The phototoxicity of aged human retinal melanosomes | Q46845824 | ||
| The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. | Q50511473 | ||
| Quantitative assessment of total body stores of vitamin A in adults with the use of a 3-d deuterated-retinol-dilution procedure. | Q52412391 | ||
| ??? | Q94631316 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vitamin | Q34956 |
| vitamin A | Q18225 | ||
| P1104 | number of pages | 8 | |
| P304 | page(s) | 7958-7965 | |
| P577 | publication date | 2010-11-12 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Deuterium enrichment of vitamin A at the C20 position slows the formation of detrimental vitamin A dimers in wild-type rodents | |
| Deuterium Enrichment of Vitamin A at the C20 Position Slows the Formation of Detrimental Vitamin A Dimers in Wild-type Rodents | |||
| P478 | volume | 286 |
| Q34624202 | C20-D3-vitamin A slows lipofuscin accumulation and electrophysiological retinal degeneration in a mouse model of Stargardt disease |
| Q86352166 | Can Vitamin A be Improved to Prevent Blindness due to Age-Related Macular Degeneration, Stargardt Disease and Other Retinal Dystrophies? |
| Q28295779 | Chemistry of the retinoid (visual) cycle |
| Q90437090 | Effects of deficiency in the RLBP1-encoded visual cycle protein CRALBP on visual dysfunction in humans and mice |
| Q92301824 | Emerging Drug Therapies for Inherited Retinal Dystrophies |
| Q28555093 | Norbixin Protects Retinal Pigmented Epithelium Cells and Photoreceptors against A2E-Mediated Phototoxicity In Vitro and In Vivo |
| Q34074393 | Pharmacological inhibition of lipofuscin accumulation in the retina as a therapeutic strategy for dry AMD treatment |
| Q89791359 | Quantifying lipofuscin in retinal pigment epithelium in vivo by visible-light optical coherence tomography-based multimodal imaging |
| Q35846008 | Rescue of the Stargardt phenotype in Abca4 knockout mice through inhibition of vitamin A dimerization. |
| Q28075612 | Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options |
| Q33801147 | Synthesis of antioxidants for prevention of age-related macular degeneration |
| Q53325183 | The Rate of Vitamin A Dimerization in Lipofuscinogenesis, Fundus Autofluorescence, Retinal Senescence and Degeneration. |
| Q37064345 | The retina rapidly incorporates ingested C20-D₃-vitamin A in a swine model |
| Q41063126 | Towards Treatment of Stargardt Disease: Workshop Organized and Sponsored by the Foundation Fighting Blindness |
| Q36926064 | Transduction of photoreceptors with equine infectious anemia virus lentiviral vectors: safety and biodistribution of StarGen for Stargardt disease |
| Q94400988 | Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to age‐related macular degeneration |
| Q48070293 | Vitamin A and Vision |
| Q36866107 | Vitamin A-aldehyde adducts: AMD risk and targeted therapeutics |
Search more.